Citation

Fukunaga K, Sakai D, Watanabe K, Nakayama K, Kohara T, Tanaka H, Sunada S, Nabeno M, Okamoto M, Saito K, Eguchi J, Mori A, Tanaka S, Inazawa K, Horikawa T.: Discovery of novel 2-(alkylmorpholin-4-yl)-6-(3-fluoropyridin-4-yl)-pyrimidin-4(3H)-ones as orally-active GSK-3β inhibitors for Alzheimer's disease. Bioorg Med Chem Lett, Volume 25 (5), 2015

Authors

Eguchi J, Fukunaga K, Horikawa T., Inazawa K, Kohara T, Mori A, Nabeno M, Nakayama K, Okamoto M, Saito K, Sakai D, Sunada S, Tanaka H, Tanaka S, Watanabe K

Journal

Bioorg Med Chem Lett

Year

2015

DOI

10.1016/j.bmcl.2015.01.005

PubMed

25655721

Machine-readable

REST APIRDF